Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 1
2009 3
2010 1
2011 9
2012 7
2013 5
2014 7
2015 3
2017 1
2018 3
2019 2
2020 2
2021 3
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Resistant hypertension and chronotherapy.
Prkacin I, Balenovic D, Djermanovic-Dobrota V, Lukac I, Drazic P, Pranjic IK. Prkacin I, et al. Mater Sociomed. 2015 Apr;27(2):118-21. doi: 10.5455/msm.2015.27.118-121. Epub 2015 Apr 5. Mater Sociomed. 2015. PMID: 26005390 Free PMC article. Review.
[Assisted peritoneal dialysis].
Klarić D, Prkačin I. Klarić D, et al. Among authors: prkacin i. Acta Med Croatica. 2014 Apr;68(2):91-5. Acta Med Croatica. 2014. PMID: 26012144 Croatian.
Markers of cardiac injury in patients with liver cirrhosis.
Šimić S, Svaguša T, Grgurević I, Mustapić S, Žarak M, Prkačin I. Šimić S, et al. Among authors: prkacin i. Croat Med J. 2023 Oct 31;64(5):362-373. doi: 10.3325/cmj.2023.64.362. Croat Med J. 2023. PMID: 37927191 Free PMC article. Review.
DIAGNOSIS OF PULMONARY EMBOLISM 
IN THE EMERGENCY DEPARTMENT.
Rošić D, Kočet N, Simić A, Prkačin I, Nesek Adam V. Rošić D, et al. Among authors: prkacin i. Acta Clin Croat. 2022 Jun;61(Suppl 1):33-37. doi: 10.20471/acc.2022.61.s1.05. Acta Clin Croat. 2022. PMID: 36304801 Free PMC article.
67 results